Leonid Cherkassky

Surgical Oncology

593 Eddy St
Providence, RI 02903

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Increasing Use of Germline Genetic Testing in Pancreatic Ductal Adenocarcinoma and Relationship to Clinical Outcome: A Single-Institution Study.

Increasing Use of Germline Genetic Testing in Pancreatic Ductal Adenocarcinoma and Relationship to Clinical Outcome: A Single-Institution Study.

Journal: JCO precision oncology

Published: April 16, 2026

IL-36γ armored CAR T cells reprogram neutrophils to induce endogenous antitumor immunity.

IL-36γ armored CAR T cells reprogram neutrophils to induce endogenous antitumor immunity.

Journal: Cancer cell

Published: April 29, 2025

Chemotherapy switch for nonresponse or progression on neoadjuvant chemotherapy for pancreatic adenocarcinoma.

Chemotherapy switch for nonresponse or progression on neoadjuvant chemotherapy for pancreatic adenocarcinoma.

Journal: Journal of surgical oncology

Published: July 08, 2024

Multi-Omic Analysis: A Possible Platform Toward Personalized and Adaptable Cancer Treatment.

Multi-Omic Analysis: A Possible Platform Toward Personalized and Adaptable Cancer Treatment.

Journal: Annals of surgical oncology

Published: March 18, 2024

High Risk, High Reward: Frailty in Colorectal Cancer Surgery is Associated with Worse Postoperative Outcomes but Equivalent Long-Term Oncologic Outcomes.

High Risk, High Reward: Frailty in Colorectal Cancer Surgery is Associated with Worse Postoperative Outcomes but Equivalent Long-Term Oncologic Outcomes.

Journal: Annals of surgical oncology

Published: June 21, 2022

An immune-inflamed tumor microenvironment as defined by CD8 score is associated with favorable oncologic outcomes in hepatocellular carcinoma independent of measures of tumor mutational burden.

An immune-inflamed tumor microenvironment as defined by CD8 score is associated with favorable oncologic outcomes in hepatocellular carcinoma independent of measures of tumor mutational burden.

Journal: American journal of cancer research

Published: May 19, 2022

Regional CAR T cell therapy: An ignition key for systemic immunity in solid tumors.

Regional CAR T cell therapy: An ignition key for systemic immunity in solid tumors.

Journal: Cancer cell

Published: April 29, 2022

Arming T cells to infiltrate pancreatic tumours.

Arming T cells to infiltrate pancreatic tumours.

Journal: Nature biomedical engineering

Published: November 13, 2021

A case from the future of HPB surgical oncology: resection of biliary tract cancer after immunotherapy.

A case from the future of HPB surgical oncology: resection of biliary tract cancer after immunotherapy.

Journal: Journal of surgical case reports

Published: August 04, 2021

Enhanced DNA Repair Pathway is Associated with Cell Proliferation and Worse Survival in Hepatocellular Carcinoma (HCC).

Enhanced DNA Repair Pathway is Associated with Cell Proliferation and Worse Survival in Hepatocellular Carcinoma (HCC).

Journal: Cancers

Published: November 06, 2020

Gallbladder Cancer: Managing the Incidental Diagnosis.

Gallbladder Cancer: Managing the Incidental Diagnosis.

Journal: Surgical oncology clinics of North America

Published: September 02, 2019

Selecting treatment sequence for patients with incidental gallbladder cancer: a neoadjuvant approach versus upfront surgery.

Selecting treatment sequence for patients with incidental gallbladder cancer: a neoadjuvant approach versus upfront surgery.

Journal: Updates in surgery

Published: June 19, 2019

Showing 1-12 of 18

Last Updated: 09/26/2026